Access cutting-edge endometrial cancer treatment through this clinical trial at a research site in Meridian. Study-provided care at no cost to qualified participants.
Access endometrial cancer specialists in Meridian at no cost
This study follows strict safety protocols and ethical guidelines
All study-related endometrial cancer treatment provided free
This phase II trial tests whether the combination of nivolumab and ipilimumab is better than nivolumab alone to shrink tumors in patients with deficient mismatch repair system (dMMR) endometrial carcinoma that has come back after a period of time during which the cancer could not be detected (recurrent). Deoxyribonucleic acid (DNA) mismatch repair (MMR) is a system for recognizing and repairing damaged DNA. In 2-3% of endometrial cancers this may be due to a hereditary condition resulted from ge
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this endometrial cancer clinical trial in Meridian, ID
If you're searching for endometrial cancer treatment options in Meridian, ID, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Meridian research site is actively enrolling participants for this clinical trial. You'll receive care from experienced endometrial cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.